文献速递免疫规划传染病防控与疫情报告

针对新发乌苏图病毒的重组减毒嵌合疫苗的研制

Development of a live-attenuated chimeric vaccine against the emerging Usutu virus.
PubMed 文献 · Vaccine · 2024-02-02

本研究基于已获批的日本脑炎病毒(JEV)疫苗株SA14-14-2的全长感染性cDNA克隆,构建了嵌合减毒乌苏图病毒(USUV)疫苗ChinUSUV。体外实验显示ChinUSUV高效复制且遗传稳定,在多种小鼠模型中表现出显著减毒表型;单次免疫可诱导强效IgG、中和抗体及T细胞应答,被动转移免疫血清可保护乳鼠抵抗致死性同源攻击。作者认为ChinUSUV是值得进一步开发的潜在USUV疫苗候选株。

要点

  • ChinUSUV是基于JEV疫苗株SA14-14-2 cDNA克隆构建的嵌合减毒活疫苗。
  • ChinUSUV体外复制高效、遗传稳定,在小鼠模型中减毒表型显著。
  • 单次免疫诱导IgG、中和抗体和T细胞应答,血清被动转移可保护乳鼠。

核心结论

  • ChinUSUV是值得进一步开发的潜在USUV疫苗候选株。

研究设计与样本

  • 基于已获批JEV疫苗株SA14-14-2的全长感染性cDNA克隆,构建嵌合减毒USUV疫苗ChinUSUV,并开展体外和小鼠模型评价。

主要发现

  • ChinUSUV在体外高效复制并保持遗传稳定性。
  • ChinUSUV在多种小鼠模型中表现出显著减毒表型,甚至与已获批JEV疫苗相比也是如此。
  • 单次免疫ChinUSUV可诱导强效IgG、中和抗体应答及T细胞应答。
  • 被动转移ChinUSUV免疫小鼠血清可对乳鼠致死性同源攻击提供显著保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Usutu virus (USUV) is an emerging arthropod-borne flavivirus that has expanded into multiple European countries during the past several decades. USUV infection in human has been linked to severe neurological complications, and no vaccine is now available against USUV. In this work, we develop a live-attenuated chimeric USUV vaccine (termed ChinUSUV) based on the full-length infectious cDNA clone of the licensed Japanese encephalitis virus (JEV) vaccine strain SA14-14-2. In vitro studies demonstrate that ChinUSUV replicates efficiently and maintains its genetic stability. Remarkably, ChinUSUV exhibits a significant attenuation phenotype in multiple mouse models even compared with the licensed JEV vaccine. A single immunization with ChinUSUV elicits potent IgG and neutralizing antibody responses as well as T cell response. Passive transfer of sera from ChinUSUV-immunized mice confers significant protection against lethal homologous challenge in suckling mice. Taken together, our results suggest that ChinUSUV represents a potential USUV vaccine candidate that merits further development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang ZJ, Zhang RR, Wu M, et al. Development of a live-attenuated chimeric vaccine against the emerging Usutu virus. Vaccine. 2024. PMID: 38310016. doi:10.1016/j.vaccine.2024.01.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。